Company Directory > Diagnostics > ACESO (Austere environments Consortium for Enhanced Sepsis Outcomes)
ACESO (Austere environments Consortium for Enhanced Sepsis Outcomes)
↗Silver Spring, MD, USA
ACESO is a global research consortium dedicated to improving survival rates for patients with sepsis and severe infections in resource-limited and 'austere' environments. Administered by the Henry M. Jackson Foundation (HJF) and headquartered at the Naval Medical Research Center (NMRC), the organization brings together academic, non-profit, and government partners to develop host-based diagnostic and prognostic solutions.
The consortium's work focuses on bridging systems biology with point-of-care clinical management. By identifying host-based biomarkers through transcriptomics, proteomics, and metabolomics, ACESO aims to create field-deployable diagnostic tools that can differentiate between bacterial and viral infections and predict disease severity in settings where modern intensive care units are unavailable.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Infectious Disease Diagnostics & Therapeutics
SIZE & FINANCIALS
Employees:51-200
Revenue:Non-profit/Grant-funded
Founded:2010
Ownership:nonprofit
Status:operating
FUNDING
Stage:Government Funded
Total Raised:$52M+
Investors:Department of Defense (DoD), Naval Medical Logistics Command, Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND)
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (RHB-107)
Modalities:Host-based Biomarkers, Point-of-Care Diagnostics, Adaptive Platform Trials, Antivirals
Active Trials:3
Trial Phases:Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF)
Key Partnerships:Fluxergy (Point-of-care testing partnership), RedHill Biopharma (Drug evaluation collaboration), Duke University, Johns Hopkins University, FHI Clinical (CRO partner)
COMPETITION
Position:Niche Player
Competitors:Inflammatix, Cytovale, Immunexpress, Sepset Biosciences
LEADERSHIP
Key Executives:
Dr. Danielle Clark - Founder and Director
Dr. Kristen Pettrone - Director for Clinical Research
Dr. Subramaniam Krishnan - Chief Science Strategist
Scientific Founders:Dr. Danielle Clark, Dr. James Lawler
LINKS
Website:aceso-sepsis.org
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ACESO (Austere environments Consortium for Enhanced Sepsis Outcomes). The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.